Public Sector Pension Investment Board Abb Vie Inc. Transaction History

Public Sector Pension Investment Board

$18.3 Billion
Q3 2024

A detailed history of Public Sector Pension Investment Board transactions in Abb Vie Inc. stock. As of the latest transaction made, Public Sector Pension Investment Board holds 1,047,674 shares of ABBV stock, worth $184 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

1,047,674

Previous 629,664 66.39%

Holding current value

$184 Million

Previous $108 Million 91.57%

% of portfolio

1.13%

Previous 0.68%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $68.5 Million - $83.3 Million	418,010 Added 66.39%	1,047,674 $207 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $48 Million - $56 Million	-309,816 Reduced 32.98%	629,664 $108 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $63.4 Million - $72.3 Million	396,780 Added 73.11%	939,480 $171 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $48.7 Million - $54.8 Million	353,634 Added 187.04%	542,700 $84.1 Million
Q3 2023 Nov 22, 2023	SELL	$133.59 - $154.65 $74 Million - $85.6 Million	-553,757 Reduced 74.55%	189,066 $28.2 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $3.4 Million - $4.23 Million	-25,628 Reduced 3.34%	742,823 $100 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $29.1 Million - $33.5 Million	201,224 Added 35.48%	768,451 $122 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $12.8 Million - $15.4 Million	-92,700 Reduced 14.05%	567,227 $91.7 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $62.6 Million - $71.8 Million	-466,149 Reduced 41.4%	659,927 $88.6 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $374,326 - $475,891	2,720 Added 0.24%	1,126,076 $172 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $483,046 - $599,325	3,660 Added 0.33%	1,123,356 $182 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $10.1 Million - $12.7 Million	93,584 Added 9.12%	1,119,696 $152 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $2.34 Million - $2.66 Million	22,036 Added 2.19%	1,026,112 $111 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $11.6 Million - $12.9 Million	109,880 Added 12.29%	1,004,076 $113 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $19.3 Million - $21.3 Million	188,960 Added 26.79%	894,196 $96.8 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $2.94 Million - $3.97 Million	-36,550 Reduced 4.93%	705,236 $75.6 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $4.58 Million - $5.38 Million	53,329 Added 7.75%	741,786 $65 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $19.1 Million - $25.6 Million	260,727 Added 60.96%	688,457 $67.6 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $4.68 Million - $7.1 Million	-72,568 Reduced 14.5%	427,730 $32.6 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $15.4 Million - $19.2 Million	213,208 Added 74.27%	500,298 $44.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $5.04 Million - $6.06 Million	80,055 Added 38.67%	287,090 $21.7 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.16 Million - $5.32 Million	63,300 Added 44.04%	207,035 $15.1 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $3.84 Million - $4.52 Million	49,800 Added 53.02%	143,735 $11.6 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $4.68 Million - $5.77 Million	-60,100 Reduced 39.02%	93,935 $8.66 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $3.94 Million - $4.38 Million	-44,300 Reduced 22.34%	154,035 $14.6 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $9.81 Million - $11.6 Million	109,300 Added 122.76%	198,335 $18.4 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $331,236 - $443,556	3,600 Added 4.21%	89,035 $8.43 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $5.97 Million - $7.62 Million	85,435	85,435 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account

Public Sector Pension Investment Board Abb Vie Inc. Transaction History